Sanara MedTech Inc. Reports First Quarter 2026 Financial Results (Unaudited)
Net Revenue Growth of 19% and Net Profitability from Continuing Operations of $0.04 Per Fully Diluted Share for the Quarter
Open original sourceLoading market dashboard
Net Revenue Growth of 19% and Net Profitability from Continuing Operations of $0.04 Per Fully Diluted Share for the Quarter
Open original source